Cargando…

Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study

Purpose: To evaluate the overall survival of patients with oligometastatic pancreatic ductal adenocarcinoma (PDAC; metastatic tumor <4 cm, ≤2 metastatic tumors total) receiving neoadjuvant therapy, metastasectomy and/or ablation, and primary tumor resection. Methods: We performed a case–control s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandel, Pujan, Wallace, Michael B., Stauffer, John, Bolan, Candice, Raimondo, Massimo, Woodward, Timothy A., Gomez, Victoria, Ritter, Ashton W., Asbun, Horacio, Mody, Kabir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319614/ https://www.ncbi.nlm.nih.gov/pubmed/30631861 http://dx.doi.org/10.1089/pancan.2018.0011

Ejemplares similares

Total pancreatectomy: Short- and long-term outcomes at a high-volume pancreas center
por: Zakaria, Hazem M, et al.
Publicado: (2016)

Should We Resect and Discard Low Risk Diminutive Colon Polyps
por: Kandel, Pujan, et al.
Publicado: (2019)

Resection of isolated liver oligometastatic disease in pancreatic ductal adenocarcinoma: Is there a survival benefit? A systematic review
por: Halle-Smith, James M, et al.
Publicado: (2023)

Imaging modalities in synchronous oligometastatic prostate cancer
por: Futterer, Jurgen J., et al.
Publicado: (2018)

Adenoma recurrence after endoscopic mucosal resection: propensity score analysis of old and new colonoscopes and Sydney recurrence tool implementation
por: Vinsard, Daniela Guerrero, et al.
Publicado: (2018)

To resect or not to resect?—the dilemma in oligometastatic breast cancer
por: Lonardi, Sara, et al.
Publicado: (2022)

Advanced EUS Guided Tissue Acquisition Methods for Pancreatic Cancer
por: Kandel, Pujan, et al.
Publicado: (2018)

Recent advancement in EUS-guided fine needle sampling
por: Kandel, Pujan, et al.
Publicado: (2019)

Glycemic Control after Total Pancreatectomy for Intraductal Papillary Mucinous Neoplasm: An Exploratory Study
por: Jamil, Laith H., et al.
Publicado: (2012)

Feasibility of pancreaticoduodenectomy with synchronous liver metastasectomy for oligometastatic pancreatic ductal adenocarcinoma - A case-control study
por: Shao, Yi, et al.
Publicado: (2020)

Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC
por: Antonoff, Mara B., et al.
Publicado: (2022)

Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries
por: Li, Zheng, et al.
Publicado: (2023)

Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas
por: Safi, S. A., et al.
Publicado: (2021)

Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor
por: Pedrazzoli, Sergio
Publicado: (2023)

Post-EMR for colorectal polyps, thermal ablation of defects reduces adenoma recurrence: A meta-analysis
por: Kandel, Pujan, et al.
Publicado: (2022)

A narrative review of imaging for pancreas adenocarcinoma: staging, surgical considerations, and surveillance
por: Bolan, Candice W., et al.
Publicado: (2023)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Pancreatic Surgery in the Older Population: A Single Institution's Experience over Two Decades
por: Brahmbhatt, Bhaumik, et al.
Publicado: (2016)

Oligometastatic recurrence of an oesophageal adenocarcinoma at a chest drain site following radical treatment: palliative treatment or resection?
por: Wen, David, et al.
Publicado: (2018)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Imaging of Oligometastatic Disease
por: Vietti Violi, Naik, et al.
Publicado: (2022)

Oligometastatic disease and visceral resections in advanced malignant melanoma: a propensity-matched analysis
por: Urbanski, Alexander, et al.
Publicado: (2023)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Oligometastatic deposits of prostate cancer found within the sigmoid pericolic fat that was resected for colonic adenocarcinoma: a case report
por: Naumann, David N., et al.
Publicado: (2022)

Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the Literature
por: Lewis, Jennifer A, et al.
Publicado: (2018)

The biology and treatment of oligometastatic cancer
por: Reyes, Diane K., et al.
Publicado: (2015)

Radiotherapy for Oligometastatic Lung Cancer
por: Bergsma, Derek P., et al.
Publicado: (2017)

Highlights on the Management of Oligometastatic Disease
por: Alshehri, Salem M., et al.
Publicado: (2020)

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
por: Buc, Emmanuel, et al.
Publicado: (2014)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

The borderline resectable and locally advanced pancreatic ductal adenocarcinoma: Definition
por: Soweid, Assaad M.
Publicado: (2017)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

Predictors of Esophageal Stricture Formation Post Endoscopic Mucosal Resection
por: Qumseya, Bashar, et al.
Publicado: (2014)

Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach
por: Jung, Jin-On, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_edsjard1rn59cpehaubhmp1huo